MYRIAD GENETICS INC
MYGN·62855J104·US·Common Stock·Healthcare - Diagnostics & Research-13D/G
MYGN (MYRIAD GENETICS INC) is held by 124 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($40M), MILLENNIUM MANAGEMENT LLC ($30M), GLENVIEW CAPITAL MANAGEMENT, LLC ($24.4M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 65 funds bought MYGN.
124
Holders
Avg rating(28 Elite)
$353.9M
Total Value
52% (138)
Fund Consensus
65 buying - 60 selling
Who's Trading
InsiderKRKumar RashmiSell $67KJun 8, 2026
InsiderDJDonnelly Brian JTax 56K shMay 1, 2026
InsiderRSRaha Samraat S.Buy $200KMar 9, 2026
InsiderPLPhanstiel S. LouiseBuy $224KFeb 27, 2026
13F: Insider & Congress:
Showing 1-20 of 138
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer